Skip to main content
The Globe and Mail
Support Quality Journalism
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); }

Experts say more research is needed to determine the true usefulness of medical marijuana.

Dave Chan/The Globe and Mail

A new Globe and Mail investigation is raising alarming questions about the safety of cannabis being sold illegally in unregulated dispensaries. But for the thousands of Canadians who use regulated and tested medical cannabis, there is another urgent issue researchers are scrambling to address: Does it work?

Background and regulations

Health Canada has not approved the use of medical cannabis, but a court ruling requires the government to "provide reasonable access to a legal source of marijuana when authorized by a health-care practitioner."

Story continues below advertisement

Producers must pass Health Canada's application and inspection process in order to sell medical marijuana. According to the department, there are currently 34 licensed producers in Canada. More than 53,000 clients were registered with licensed producers during the period between Jan. 1 and March 31, 2016.

RELATED: Restrictions on pot-safety testing put public at risk, scientists warn

There are also an unknown number of Canadians who are allowed to grow their own medical marijuana at home as a result of a 2014 court decision. A ruling earlier this year struck down a ban on homegrown medical marijuana; the government is expected to bring in new rules by the end of the summer.

Doctors can decide if and when patients should qualify for medical marijuana. But this puts them in a difficult situation, as it has not been approved by the government to treat any medical condition.

Canadian Medical Association president Cindy Forbes said in a statement that the current regulatory environment is "a serious challenge for physicians in providing the best care to patients."

FEATURE: Washington State's road to legal marijuana strewn with potholes

Unanswered questions

Story continues below advertisement

There's no shortage of anecdotal evidence from individuals who claim cannabis lessens their pain, combats the symptoms of chemotherapy or reduces their anxiety. But there are no large high-quality scientific studies to back any of those statements.

"We need to see if, in fact, it's legitimate by the standards of medical science," said M-J Milloy, an assistant professor of medicine at the University of British Columbia.

The active ingredients of cannabis that are believed to have therapeutic effects are called cannabinoids. They include compounds such as tetrahydrocannabinol (THC) and cannabinol (CBN). Although the mechanisms aren't entirely clear, it's believed cannabinoids work by binding to receptors found in the body.

The major obstacle that has long stood in the way is the lack of funding along with the stigma associated with studying cannabis. Governments wouldn't allow researchers access to it, few funds were available for studies and most researchers didn't want their names tied to the drug. There are a number of cannabis producers who are also becoming involved in medical research, and some experts have warned about the potential conflict of interest this could pose.

Although things have started to change, there's still a long way to go, Dr. Milloy said.

So far, the research into medical cannabis has produced mixed results. In June, 2015, the Journal of the American Medical Association published an analysis of 80 studies looking at its efficacy.

Story continues below advertisement

Researchers found some evidence that cannabinoids can reduce chronic pain and the muscle contractions or involuntary movements suffered by many with multiple sclerosis. But there was little proof it helps reduce anxiety, nausea and other symptoms of chemotherapy or sleep disorders. Researchers also couldn't find evidence to show cannabis promotes weight gain in HIV patients.

The future

The research is still in its infancy. Experts believe that, as more work is done in this area, the true usefulness of medical cannabis will finally become clear.

Jason McDougall is one of the scientists hoping to answer some of those questions. The Dalhousie University professor and pain researcher is currently conducting a trial studying the effectiveness of cannabinoids for osteoarthritis pain. The study was funded by the Arthritis Society, an example of how patient groups are moving to embrace the potential medical uses of cannabis.

Like many other researchers in the field, Dr. McDougall isn't studying marijuana that's smoked, vaporized or eaten. He's looking at specific cannabis molecules isolated from the plant. Many researchers believe that, once the research is complete, cannabinoids will be made available in pill form.

What's needed now, experts say, is more research funding to clarify what medical cannabis can be used for and to provide doctors with much-needed guidance.

Story continues below advertisement

Dr. Forbes said in a statement that the Canadian Medical Association "calls on Health Canada and research agencies to fund the scientific research needed" to provide evidence for medical marijuana.

Dr. Milloy agrees, saying the work needs to be done in order to give patients the answers they deserve. "I think the time has passed where medical researchers can say this is all malarkey," he said. "It's not malarkey. There is something here. Our responsibility is to try and test it with all the rigour it demands."

Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies